Rossmore Private Capital’s TELA Bio TELA Stock Holding History

Rossmore Private Capital’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-34,484	Closed	-$519K	–	216
2020 Q4	$519K	Buy	34,484 +24,484	+245%	+$397K	0.11%	141
2020 Q3	$165K	Buy	+10,000	New	+$140K	0.04%	188

Other funds holding TELA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Rossmore Private Capital's TELA Position: Q1 2021 in Review

Rossmore Private Capital sold out of TELA Bio (TELA) in Q1 2021, closing a stake of 34,484 shares — an estimated $519K sold.

Rossmore Private Capital first reported a position in TELA in Q3 2020 and held it in 2 quarters. The position peaked at $519K in Q4 2020. 47 funds tracked by Wall St. Rank hold TELA as of Q1 2021.

Rossmore Private Capital reported no remaining TELA Bio position as of Q1 2021 after selling out during the quarter.
Rossmore Private Capital sold 34,484 TELA Bio shares in Q1 2021, an estimated $519K.
Rossmore Private Capital first reported a position in TELA Bio in Q3 2020 and held it in 2 quarters.
Rossmore Private Capital's TELA Bio position peaked at $519K in Q4 2020.
47 funds tracked by Wall St. Rank held TELA Bio as of Q1 2021.

Based on Rossmore Private Capital's 13F filing for Q1 2021, filed 10 May 2021.